{"database": "lobbying", "table": "lobbying_activities", "rows": [[539878, "fdd1543d-af24-486f-be6f-7dcc6a295ef0", "Y@", "ML STRATEGIES, LLC", 25603, "NOVARTIS PHARMACEUTICALS", 2007, "year_end", "HCR", "S 484, Enhancing Drug Safety and Innovation Act of 2007, Title 1, drug safety; and Title 3, clinical trials registry and results.\nFederal Food, Drug and Cosmetic Act (21 USC 301), Chapters 1-9 as they relate to the review, approval and regulation of drugs biologics and devices.", "HOUSE OF REPRESENTATIVES,SENATE", 100000, null, 0, 0, "2007-12-05T15:07:11-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["539878"], "units": {}, "query_ms": 2.6275779819115996, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}